The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous Carcinomas

被引:134
|
作者
Salvador, Shannon [1 ]
Gilks, Blake [2 ]
Koebel, Martin [3 ,5 ,6 ]
Huntsman, David [2 ,3 ,5 ]
Rosen, Barry [7 ]
Miller, Dianne [1 ,4 ]
机构
[1] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada
[2] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1M9, Canada
[3] Vancouver Coastal Hlth Res Inst, Dept Pathol, Vancouver, BC, Canada
[4] Vancouver Coastal Hlth Author, Dept Gynecol Oncol, Vancouver, BC, Canada
[5] British Columbia Canc Agcy, Dept Pathol, Vancouver, BC V5Z 4E6, Canada
[6] Charita Hosp, Inst Pathol, Berlin, Germany
[7] Princess Margaret Hosp, Dept Gynecol Oncol, Toronto, ON M4X 1K9, Canada
关键词
High-grade serous carcinoma; Fallopian tube carcinoma; Ovarian cancer; Etiology; EPITHELIAL OVARIAN-CANCER; ORAL-CONTRACEPTIVE USE; INFLAMMATORY-DISEASE; PROPHYLACTIC OOPHORECTOMY; NEISSERIA-GONORRHOEAE; PATHOLOGICAL FINDINGS; MUTATION CARRIERS; FERTILITY DRUGS; HEALTH-BENEFITS; ORGAN-CULTURE;
D O I
10.1111/IGC.0b013e318199009c
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial ovarian cancer is the most common cause of mortality from gynecologic malignancy, and most of epithelial cancers are of serous type. The site of origin of pelvic high-grade serous carcinoma has been the subject of debate for 60 years. This paper reviews the evidence that pelvic serous carcinoma originates from the fallopian tube mucosa and puts forward a theory that inflammation in the tube, caused by menstrual cytokines or infection, is critical to the genesis of these tumors. Other risk factors for pelvic serous carcinoma will be reviewed, including oral contraceptive use, parity, infertility, and tubal ligation. Studies were identified for this review by searching the English language literature in the MEDLINE database between the years 1995 and 2007 using the following keywords: fallopian tube neoplasia, ovarian serous adenocarcinoma, pregnancy, oral contraceptive, infertility, pelvic inflammatory disease, cytokines, menstruation, and tubal ligation, followed by an extensive review of bibliographies from articles found through the search. The clinical implications of this theory are discussed, and a change in surgical practice is recommended, with salpingectomy at the time of simple hysterectomy. This theory also has implications for the development of new methods of screening for pelvic serous carcinomas, as there are no screening methods that arc currently available to find this form of cancer in an early stage. Inflammatory markers could be detected in the vagina from the fallopian tube indicating possible chronic inflammation and a risk factor for mutagenesis leading to serous carcinoma.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 50 条
  • [21] Bulky peritoneal carcinosarcoma with tiny high-grade serous carcinoma of the fallopian tube: a case report
    Nakashima, Ayaka
    Maruyama, Yasuyo
    Saji, Haruya
    Hirabuki, Tomoo
    Mitomi, Hiroyuki
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2021, 10 (01) : 72 - 77
  • [22] Fallopian Tube High-grade Serous Carcinoma With Intramucosal Spread and Presenting as a Malignancy on Pap Smear
    Kos, Zuzana
    Broaddus, Russell R.
    Djordjevic, Bojana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2014, 33 (04) : 443 - 448
  • [23] Mechanisms of High-Grade Serous Carcinogenesis in the Fallopian Tube and Ovary: Current Hypotheses, Etiologic Factors, and Molecular Alterations
    Otsuka, Isao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [24] Comparison Of Early-Stage High-Grade Serous Primary Fallopian Tube Cancers and Epithelial Ovarian Cancers: A Multicenter Study
    Gungorduk, Kemal
    Ozdemir, Aykut
    Selcuk, Ilker
    Telli, Elcin
    Sahin, Ozturk
    Toptas, Tayfun
    Akman, Levent
    Guzel, Ahmet B.
    Taskin, Salih
    Oge, Tufan
    Gungorduk, Ozgu
    Gokcu, Mehmet
    Gungor, Tayfun
    Yasar, Levent
    Terek, Mustafa C.
    Ozan, Hakan
    Ozsaran, Aydin
    Sanci, Muzaffer
    Vardar, Mehmet A.
    Meydanli, Mehmet M.
    Yalcin, Omer T.
    Ortac, Firat
    Ozalp, Sinan
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (04) : 203 - 206
  • [25] The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas
    Koebel, Martin
    Reuss, Alexander
    du Bois, Andreas
    Kommoss, Stefan
    Kommoss, Friedrich
    Gao, Dongxia
    Kalloger, Steve E.
    Huntsman, David G.
    Gilks, C. Blake
    JOURNAL OF PATHOLOGY, 2010, 222 (02) : 191 - 198
  • [26] Signal transduction pathway activity in high-grade serous carcinoma, its precursors and Fallopian tube epithelium
    van der Ploeg, Phyllis
    Uittenboogaard, Aniek
    Bosch, Steven L.
    van Diest, Paul J.
    Wesseling-Rozendaal, Yvonne J. W.
    van de Stolpe, Anja
    Lambrechts, Sandrina
    Bekkers, Ruud L. M.
    Piek, Jurgen M. J.
    GYNECOLOGIC ONCOLOGY, 2022, 165 (01) : 114 - 120
  • [27] Key features of extrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum)
    DeLair, Deborah
    Soslow, Robert A.
    HISTOPATHOLOGY, 2012, 61 (03) : 329 - 339
  • [28] The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum
    Toptas, Tayfun
    Pestereli, Elif
    Simsek, Tayup
    Bozkurt, Selen
    Erdogan, Gulgun
    Karaveli, Seyda
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (03) : 587 - 592
  • [29] Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum
    Takuma Ohsuga
    Ken Yamaguchi
    Aki Kido
    Ryusuke Murakami
    Kaoru Abiko
    Junzo Hamanishi
    Eiji Kondoh
    Tsukasa Baba
    Ikuo Konishi
    Noriomi Matsumura
    BMC Cancer, 17
  • [30] A 3-Tier Chemotherapy Response Score for Ovarian/Fallopian Tube/Peritoneal High-grade Serous Carcinoma Is it Clinically Relevant?
    Lawson, Barrett C.
    Euscher, Elizabeth D.
    Bassett, Roland L.
    Liu, Jinsong
    Ramalingam, Preetha
    Zhong, YanPing
    Fleming, Nicole D.
    Malpica, Anais
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (02) : 206 - 213